Solube receptor for advanced glycation end products in patients with renal impairment and hemodialysis patients / Ahmed Farag Ahmed ; Supervised Hanan Abdelhalim Abdelrahim , Mona Mohamed Roshdy , Layila Rashed
Material type:
- المستقبلات الذاتية لنواتج التسكير النهائية المتقدمة فى مرضى قصور وظائف الكلى ومرضى الغسيل الكلوى [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.18.M.Sc.2011.Ah.S (Browse shelf(Opens below)) | Not for loan | 01010110055565000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.18.M.Sc.2011.Ah.S (Browse shelf(Opens below)) | 55565.CD | Not for loan | 01020110055565000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Internal Medicine
Solube RAGE is a naturally occurring inhibitor of pathological effects mediated via RAGE . Protective sRAGE levels are decreased in patients with coronary artery disease as well as in patients with hypertension . Patients with decrease renal function arre at high cardiovascular risk and often have hypertension or diabetes factors that decrease renal function
Issued also as CD
There are no comments on this title.